Clinical outcomes and lung toxicities after lung SABR using dynamic conformal arc therapy: a single-institution cohort study

Clinical outcomes and lung toxicities after lung SABR using dynamic conformal arc therapy: a single-institution cohort study

Abstract Background Stereotactic ablative radiotherapy (SABR) is a validated treatment for early stage lung cancer and pulmonary metastases. It provides a high local control rate with low symptomatic toxicities. Recently, Dynamic Conformal Arc Therapy (DCAT), a delivery option that differs from conv...

Full description

Bibliographic Details
Main Authors: Emmanuel Mesny, Myriam Ayadi, Pauline Dupuis, Guillaume Beldjoudi, Ronan Tanguy, Isabelle Martel-Lafay
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Radiation Oncology
Subjects:
Lung SABR
DCAT
Radiation pneumonitis
Online Access:https://doi.org/10.1186/s13014-023-02227-2

Internet

https://doi.org/10.1186/s13014-023-02227-2

Similar Items